Moelis & Company (MC)
| Market Cap | 4.49B -13.1% |
| Revenue (ttm) | 1.57B +13.7% |
| Net Income | 228.26M +15.2% |
| EPS | 3.08 +15.4% |
| Shares Out | 81.12M |
| PE Ratio | 17.95 |
| Forward PE | 15.22 |
| Dividend | $2.60 (4.70%) |
| Ex-Dividend Date | Aug 10, 2026 |
| Volume | 1,260,970 |
| Open | 54.46 |
| Previous Close | 54.27 |
| Day's Range | 53.80 - 55.41 |
| 52-Week Range | 51.06 - 78.22 |
| Beta | 1.90 |
| Analysts | Hold |
| Price Target | 67.50 (+22.02%) |
| Earnings Date | Nov 5, 2026 |
About MC
Moelis & Company operates as an investment banking advisory company in North and South America, Europe, the Middle East, Asia, and Australia. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic advisory, capital markets, capital structure advisory, and private capital advisory. The company serves public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, gover... [Read more]
Financial Performance
In 2025, Moelis & Company's revenue was $1.52 billion, an increase of 26.98% compared to the previous year's $1.19 billion. Earnings were $233.04 million, an increase of 71.33%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for MC stock is "Hold." The 12-month stock price target is $67.5, which is an increase of 22.02% from the latest price.
News
Moelis & Company to Announce Third Quarter 2026 Financial Results and Host a Conference Call on November 5, 2026
NEW YORK--(BUSINESS WIRE)--Moelis & Company to announce Third Quarter 2026 financial results and host a conference call on November 5, 2026.
Moelis price target lowered to $68 from $74 at BofA
BofA lowered the firm’s price target on Moelis (MC) to $68 from $74 and keeps a Neutral rating on the shares. Global strategic and sponsor M&A momentum weakened markedly quarter-over-quarter,…
Moelis price target lowered to $77 from $85 at Morgan Stanley
Morgan Stanley analyst Ryan Kenny lowered the firm’s price target on Moelis (MC) to $77 from $85 and keeps an Overweight rating on the shares as part of an earnings…
Moelis upgraded to Neutral from Sell at UBS
UBS upgraded Moelis (MC) to Neutral from Sell with a price target of $59, down from $60. The merger and acquisition backdrop, particularly within sponsor activity, remains challenging, and Moelis’…
Moelis upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette upgraded Moelis (MC) to Outperform from Market Perform with a price target of $66, down from $68. The firm shifted preferences in the mergers and acquisition independents group…
Moelis price target lowered to $60 from $72 at BMO Capital
BMO Capital lowered the firm’s price target on Moelis (MC) to $60 from $72 and keeps a Market Perform rating on the shares as part of a broader research note…
Moelis price target lowered to $62 from $71 at Goldman Sachs
Goldman Sachs analyst James Yaro lowered the firm’s price target on Moelis (MC) to $62 from $71 and keeps a Neutral rating on the shares.
Moelis price target raised to $75 from $70 at Deutsche Bank
Deutsche Bank analyst Nathan Stein raised the firm’s price target on Moelis (MC) to $75 from $70 and keeps a Buy rating on the shares. The firm views the company’s…
Moelis price target raised to $85 from $83 at Morgan Stanley
Morgan Stanley analyst Ryan Kenny raised the firm’s price target on Moelis (MC) to $85 from $83 and keeps an Overweight rating on the shares. Management attributed the revenue beat…
Moelis & Company Earnings Call Transcript: Q2 2026
Q2 and H1 2026 set revenue records, driven by strong M&A, capital markets, and private capital advisory performance. Margins improved, expenses rose with business activity, and the firm entered H2 with a record pipeline and robust outlook.
Moelis & Company Earnings release: Q2 2026
Moelis & Company released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Moelis & Company Quarterly report: Q2 2026
Moelis & Company has published its Q2 2026 quarterly earnings report on July 29, 2026.
Moelis & Company Slides: Q2 2026
Moelis & Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
NEW YORK--(BUSINESS WIRE)--Moelis & Company reports Second Quarter and First Half 2026 financial results; declares regular quarterly dividend of $0.65 per share.
Moelis price target lowered to $66 from $69 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Moelis (MC) to $66 from $69 and keeps a Market Perform rating on the shares.
Moelis cut to Sell at UBS on overly optimistic expectations
UBS analyst Michael Brown downgraded Moelis (MC) to Sell from Neutral with a price target of $60, up from $58. The firm contends that the stock’s risk-reward is increasingly skewed…
Moelis downgraded to Sell from Neutral at UBS
UBS downgraded Moelis (MC) to Sell from Neutral with a price target of $60, up from $58.
Distressed-debt funds in talks to swap Strategy preferred shares, Bloomberg says
Distressed-debt funds that snapped up Strategy’s (MSTR) beaten-down preferred shares are in talks with Moelis (MC) about exchanging their holdings for other preferred shares at a discounted price, or ...
Moelis & Company Transcript: Morgan Stanley US Financials Conference 2026
Leadership is focused on expanding capabilities, maintaining a collaborative culture, and hiring top talent. M&A and capital markets activity remain strong, with AI driving strategic decisions and sector shifts. Investments in AI and new business lines support long-term growth.
Moelis files to sell Class A common stock, no amount given
17:20 EDT Moelis (MC) files to sell Class A common stock, no amount given
Moelis & Company Proxy statement: Proxy filing
Moelis & Company filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Moelis & Company Proxy statement: Proxy filing
Moelis & Company filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.
Moelis price target raised to $69 from $64 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on Moelis (MC) to $69 from $64 and keeps an Outperform rating on the shares.
Moelis & Company Earnings Call Transcript: Q1 2026
Record Q1 revenues rose 4% year-over-year, driven by strong M&A and private capital advisory, with robust hiring and a record pipeline supporting a positive outlook. Compensation and expense ratios improved, and $171 million was returned to shareholders.
Moelis & Company Earnings release: Q1 2026
Moelis & Company released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.